$GLSI Yet ANOTHER Inside Buy! 👏🏻👏🏻👏🏻 Snehal Patel, CEO and CFO has demonstrated one of the most consistent patterns of insider buying in the biotech sector. 👍 According to SEC Form 4 filings, he has completed more than 70 open-market purchases of GLSI common stock since 2021, totaling approximately $6.5 million, with zero reported sales. 💥💥 His most recent transactions include: • July 23, 2026: 2,500 shares at $13.14 • July 24, 2026: 1,100 shares at $12.88 • July 27, 2026: 1,500 shares at $13.62 Following these purchases, Patel beneficially owns more than 5.6 million shares. This sustained buying activity, executed entirely with personal capital and without any offsetting sales, signals strong alignment between management and shareholders. 💰💰💰 It reflects confidenc
在 X 查看 ↗